Efficacy and Safety of Revefenacin for Nebulization in Patients With Chronic Obstructive Pulmonary Disease Taking Concomitant ICS/LABA or LABA: Subgroup Analysis From Phase III Trials
Therapeutic Advances in Respiratory Disease - United Kingdom
doi 10.1177/1753466620905278
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
SAGE Publications